Turner William D. 4
4 · Vera Therapeutics, Inc. · Filed Jan 9, 2024
Insider Transaction Report
Form 4
Turner William D.
Chief Regulatory Officer
Transactions
- Award
Stock Option (right to buy)
2024-01-05+275,000→ 275,000 totalExercise: $15.53Exp: 2034-01-04→ Class A Common Stock (275,000 underlying)
Footnotes (1)
- [F1]1/4 of the shares subject to the option vest on January 5, 2025, and 1/48 of the shares vest monthly thereafter, subject to continuous service of the Reporting Person through each vesting date.